share_log

6-K: Voting Rights and Capital

6-K: Voting Rights and Capital

6-K:投票權和資本
美股SEC公告 ·  2024/11/01 15:47

牛牛AI助理已提取核心訊息

AstraZeneca has reported its total voting rights and capital status as of October 31, 2024. The company's issued share capital with voting rights consists of 1,550,303,887 ordinary shares of US$0.25 each. No shares are currently held in Treasury.This disclosure, made in compliance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1, provides shareholders with the denominator figure for calculating their interest notifications in the company. The total number of voting rights remains at 1,550,303,887.
AstraZeneca has reported its total voting rights and capital status as of October 31, 2024. The company's issued share capital with voting rights consists of 1,550,303,887 ordinary shares of US$0.25 each. No shares are currently held in Treasury.This disclosure, made in compliance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1, provides shareholders with the denominator figure for calculating their interest notifications in the company. The total number of voting rights remains at 1,550,303,887.
阿斯利康已報告截至2024年10月31日的總投票權和資本狀況。公司已發行的具有投票權的股份資本由1,550,303,887股面值爲0.25美元的普通股組成。目前沒有股份被保存在國庫中。該披露是根據英國金融行爲監管局的披露和透明度規則5.6.1作出的,向股東提供了計算其在公司的權益通知量的分母數字。投票權的總數保持在1,550,303,887。
阿斯利康已報告截至2024年10月31日的總投票權和資本狀況。公司已發行的具有投票權的股份資本由1,550,303,887股面值爲0.25美元的普通股組成。目前沒有股份被保存在國庫中。該披露是根據英國金融行爲監管局的披露和透明度規則5.6.1作出的,向股東提供了計算其在公司的權益通知量的分母數字。投票權的總數保持在1,550,303,887。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
評論 評論 · 瀏覽 415

熱點推薦

聲明

本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。